Detalhe da pesquisa
1.
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia.
N Engl J Med
; 386(16): 1519-1531, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35443108
2.
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
Blood
; 141(2): 156-167, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714312
3.
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status.
Blood
; 139(14): 2145-2155, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995344
4.
Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 103(4): 1187-1196, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291275
5.
Evaluating the economic burden of acute myeloid leukemia in Canada.
Acta Haematol
; 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38382483
6.
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis.
Eur J Haematol
; 110(6): 618-625, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732677
7.
Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-Analysis.
Value Health
; 26(12): 1689-1696, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741447
8.
Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia.
Acta Haematol
; 146(5): 366-372, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315549
9.
A 17-gene stemness score for rapid determination of risk in acute leukaemia.
Nature
; 540(7633): 433-437, 2016 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926740
10.
Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial.
Lancet Oncol
; 22(11): 1597-1608, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34672961
11.
3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?
Curr Oncol Rep
; 23(10): 120, 2021 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34350512
12.
Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy.
Br J Haematol
; 191(5): 748-754, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32395867
13.
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
N Engl J Med
; 376(9): 836-847, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249141
14.
Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab.
Blood
; 131(26): 2906-2914, 2018 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29739753
15.
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia.
Nature
; 506(7488): 328-33, 2014 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24522528
16.
Aplastic anaemia in pregnancy - a single centre, North American series.
Br J Haematol
; 184(3): 436-439, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30460693
17.
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.
Haematologica
; 109(2): 671-675, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345484
18.
A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy.
Support Care Cancer
; 27(6): 2295-2300, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341536
19.
Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QUAZAR AML-001 trial.
Haematologica
; 108(10): 2820-2825, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951156
20.
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.
Blood
; 126(3): 291-9, 2015 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25987659